Bowstring Advisors Adds Managing Director to Expand Healthcare Services Practice

  • Healthcare Services

June 17, 2014 | Atlanta, GA

Bowstring Advisors is pleased to announce that Ross DeDeyn has joined the firm as a Managing Director – Healthcare to advise growth-oriented healthcare services companies. Over the last decade, Ross has worked on healthcare transactions totaling over $4 billion in enterprise value.

Prior to Bowstring, Ross worked in the Atlanta office of Memphis-based Duncan-Williams, Inc., a middle-market investment bank, providing merger and acquisition advisory services in the healthcare and business services industries.

Previously, Ross was with Piper Jaffray’s Healthcare Team in New York where he executed equity capital markets and merger and acquisition transactions for public and private companies in the healthcare services space. Before Piper Jaffray, Ross began his career in investment banking with the UBS Healthcare Team in New York. He holds an MBA from Columbia Business School and a JD from the University of Georgia School of Law.

Jim Childs, Managing Director, commented, “We are very pleased to have Ross join our team. Healthcare is a very important sector to us and fits perfectly with our focus on advising high growth outsourcing services and technology firms. As the leading advisor to healthcare IT services firms, it is a natural next step to expand into healthcare services and technology sub-sectors. Ross brings sector expertise, big bank experience and the entrepreneurial DNA that we value at Bowstring.”

Ross can be reached at rdedeyn@bowstringadvisors.com or 404.751.3018.

“We are very pleased to have Ross join our team. Healthcare is a very important sector to us and fits perfectly with our focus on advising high growth outsourcing services and technology firms. As the leading advisor to healthcare IT services firms, it is a natural next step to expand into healthcare services and technology sub-sectors. Ross brings sector expertise, big bank experience and the entrepreneurial DNA that we value at Bowstring.”

Jim Childs
Founder and CEO
Bowstring Advisors